Phreesia Net Profit Margin 2019-2025 | PHR
Phreesia net profit margin from 2019 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Phreesia Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-10-31 | $0.46B | $-0.01B | -1.08% |
| 2025-07-31 | $0.45B | $-0.02B | -5.11% |
| 2025-04-30 | $0.44B | $-0.04B | -9.66% |
| 2025-01-31 | $0.42B | $-0.06B | -13.81% |
| 2024-10-31 | $0.41B | $-0.08B | -20.49% |
| 2024-07-31 | $0.39B | $-0.10B | -25.90% |
| 2024-04-30 | $0.37B | $-0.12B | -32.09% |
| 2024-01-31 | $0.36B | $-0.14B | -38.66% |
| 2023-10-31 | $0.34B | $-0.15B | -42.77% |
| 2023-07-31 | $0.32B | $-0.15B | -47.81% |
| 2023-04-30 | $0.30B | $-0.16B | -53.97% |
| 2023-01-31 | $0.28B | $-0.18B | -62.63% |
| 2022-10-31 | $0.26B | $-0.18B | -70.23% |
| 2022-07-31 | $0.25B | $-0.18B | -73.47% |
| 2022-04-30 | $0.23B | $-0.16B | -68.86% |
| 2022-01-31 | $0.21B | $-0.12B | -54.93% |
| 2021-10-31 | $0.20B | $-0.08B | -40.10% |
| 2021-07-31 | $0.18B | $-0.05B | -27.93% |
| 2021-04-30 | $0.16B | $-0.03B | -19.63% |
| 2021-01-31 | $0.15B | $-0.03B | -18.24% |
| 2020-10-31 | $0.14B | $-0.02B | -16.55% |
| 2020-07-31 | $0.13B | $-0.02B | -13.43% |
| 2020-04-30 | $0.13B | $-0.08B | -63.85% |
| 2020-01-31 | $0.13B | $-0.09B | -73.60% |
| 2019-07-31 | $0.08B | $-0.10B | -117.86% |
| 2019-04-30 | $0.08B | $-0.04B | -51.28% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.720B | $0.420B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $28.621B | 33.10 |
| Tempus AI (TEM) | United States | $9.242B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $4.646B | 0.00 |
| Doximity (DOCS) | United States | $4.621B | 20.02 |
| Hims & Hers Health (HIMS) | United States | $3.711B | 30.18 |
| Hinge Health (HNGE) | United States | $3.065B | 0.00 |
| Privia Health (PRVA) | United States | $2.754B | 172.23 |
| 10x Genomics (TXG) | United States | $2.293B | 0.00 |
| Heartflow (HTFL) | United States | $1.759B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.736B | 23.16 |
| Omnicell (OMCL) | United States | $1.638B | 45.62 |
| Azenta (AZTA) | United States | $1.318B | 53.00 |
| Enovis (ENOV) | United States | $1.245B | 6.54 |
| Clover Health Investments (CLOV) | United States | $1.044B | 0.00 |
| Schrodinger (SDGR) | United States | $0.840B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.768B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.724B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.431B | 0.00 |
| Claritev (CTEV) | United States | $0.380B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.338B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| TruBridge (TBRG) | United States | $0.293B | 13.45 |
| Carlsmed (CARL) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.160B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.151B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 5.40 |
| American Well (AMWL) | United States | $0.088B | 0.00 |
| 111 (YI) | China | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.032B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.017B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.005B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |